Roundup and analysis of the top headlines on health security, pandemic preparedness, COVID-19, and other news from the Johns Hopkins Center for Health Security


Please note that some links may require subscription or registration.

August 22, 2024



NOTICE: Health Security Decoded is taking a break next week and will not be published on August 29. We will be back on September 5.

TOP NEWS

Clade Ib mpox detected outside of Africa in Sweden, Thailand; mpox vaccine donations, orders ramp up; Africa CDC hopes first shots to begin next week


Since Africa CDC declared mpox a public health emergency of continental security (PHECS) in Africa on August 13, 2024, and WHO declared mpox a public health emergency of international concern (PHEIC) on August 14, 2024, cases of mpox clade Ib virus have been detected outside Africa for the first time, underscoring the urgent need for a global response.


  • As we noted in last week’s edition, Sweden on August 15 reported the first case of the more infectious clade Ib mpox virus outside of Africa. The person was infected during a stay in the African region where the clade was first identified.
  • Today, Thailand became the second country outside of Africa to confirm a case of clade Ib mpox. That case is in a 66-year-old European man who had recently visited an unspecified country in Africa where the disease is spreading.
  • The Democratic Republic of the Congo (DRC), where clade Ib was first identified, reported more than 1,000 new mpox cases in the week leading up to August 20. DRC has recorded the majority of the 17,541 cases and 517 deaths in Africa this year.
  • Burundi, which had never reported an mpox case until recently, has the highest number of cases in Eastern Africa, recording at least 170 confirmed cases as of August 20 and more than 600 suspected cases.
  • Researchers are working to better understand transmission modes and patterns of both clade Ia, the most prevalent strain, and clade Ib in the Central Africa region, which includes transmission between household members, patients and healthcare workers, and sexual partners, as well as likely between infected animals, such as rodents, and people. In DRC, about 80% of known clade Ia cases are among children.


Response Efforts

Countries and organizations are ramping up their responses to the PHEIC.


  • USAID announced an additional US$35 million in emergency health assistance for the clade I mpox outbreak in Central and East Africa. The funding, bringing the total pledged to US$55 million, will assist with surveillance, diagnostics, risk communication, and vaccination planning and coordination. The US previously said it will donate 50,000 mpox vaccine doses to DRC.
  • The European Commission last week announced it will donate more than 215,000 doses of the MVA-BN vaccine in collaboration with the manufacturer, Bavarian Nordic.
  • France this week announced it will donate 100,000 mpox vaccine doses.
  • Bavarian Nordic said it could ramp up production of its mpox vaccine, known as JYNNEOS in the US, to provide 2.5 million doses by the end of this year and another 8 million by the end of next year. However, the company said it needs to receive orders for the product in order to do so.
  • An “undisclosed” European country this week placed an order with Bavarian Nordic for 440,000 doses of smallpox and mpox vaccine.
  • Africa CDC is in talks with Bavarian Nordic about a technology transfer to enable African manufacturers to produce the vaccine on the continent, but a company official previously said there are no plans to sell or manufacture its vaccines directly to African countries. Africa CDC is aiming to have 10 million vaccine doses available by the end of 2025.
  • Emergent BioSolutions announced this week it will donate 50,000 doses of its ACAM2000 smallpox vaccine, which is also authorized for use against mpox virus.
  • Japan has pledged to send 3.5 million doses of LC16 vaccine, made by KM Biologics, to DRC. Japan requested that the vaccine be used specifically for children, who are more susceptible to severe mpox disease.
  • Gavi said it has up to US$500 million to spend on vaccines once they are authorized by WHO, a process that is underway.
  • Africa CDC said vaccines are expected to arrive soon in DRC and other countries, and they hope to begin administering shots as soon as next week.
  • Roche said it is actively working with partners to enhance mpox laboratory capacity worldwide to develop and improve access to rapid and high-quality PCR testing.
  • UNICEF is appealing for US$16.5 million for its mpox response in the Central and East Africa region, while the UN International Organization for Migration (IOM) appealed this week for US$18.5 million to provide healthcare services to impacted populations in East and Southern Africa.
  • China and other Asian nations announced increased border protections amid the PHEIC. African health officials urged the international community not to impose travel bans on countries experiencing mpox outbreaks but instead support them in ramping up testing and vaccinations. 


Expert Commentaries

Several commentaries on the mpox emergency were published this week, including a viewpoint piece in JAMA authored by Center for Health Security Senior Scholars Drs. Caitlin Rivers, Crystal Watson, and Alexandra Phelan. They write, “Failure to act decisively in response to the global alert would be an injustice that reinforces inequities in how health emergencies are prioritized and whose lives are saved. This would undermine the utility of international law and reveal commitments as empty promises, putting the whole world at greater risk of this outbreak and the next.” In a LinkedIn post, Center for Health Security Director Dr. Tom Inglesby noted that “we need an international plan for how mpox vaccine will be rapidly deployed and used—what is the concept of operations of who should be vaccinated, where is the risk greatest, what vaccine interventions would have the greatest impact.”


Other recent commentaries on mpox include:

New York Times: Another Pandemic Looms. Guess What? We’re Still Not Ready.

STAT: Graphic mpox images to educate the public are deeply problematic

The Guardian: The Guardian view on Africa’s mpox outbreak: Covid lessons need to be learned

Time: It’s Time to Start Taking Mpox and Bird Flu Seriously

The Guardian: The new mpox variant may appear to be less deadly but it is spreading fast. Complacency would be a grave error


MORE HEADLINES

Summer COVID-19 wave still rising, shows slowdown in some regions; KP.3.1.1 variant makes up estimated 37% of new cases

AP: COVID-19 is on the upswing in the U.S.

CIDRAP: COVID activity shows signs of slowing in parts of US

USA Today: COVID-19 variant KP.3.1.1 now makes up nearly 40% of cases, new CDC data shows

NPR: The CDC says COVID is endemic. That doesn't mean the danger is past

See also: NYT: Many People Are Eligible for Paxlovid. Who Should Take It?


Nearly one-third of poll respondents say COVID poses health risk, more than half say pandemic over

Axios: Axios-Ipsos poll: Uptick in Americans feeling COVID risk

The Hill: 1 in 3 say COVID poses risk to their health: Survey


Long COVID symptoms in youth different than in adults, vary based on age groups, research shows

USA Today: Teens and kids with long COVID are showing surprising new symptoms

Time: Long COVID Looks Different in Kids

STAT: Long Covid symptoms in kids aren’t one-size-fits-all, study shows


Severe COVID associated with higher risk of depression, mental illness; rates highest in pre-vaccine era, study says

CNN: Covid tied to higher risk of depression, anxiety, PTSD and other conditions, with the unvaccinated most affected, study shows

MedPage Today: Severe COVID Linked to Mental Illness in Weeks, Months After Infection


US FDA expected to green light updated COVID vaccines soon; supplies of current boosters running low

NPR: Updated COVID vaccines are coming soon

NBC News: A new Covid vaccine is expected soon. Here's the best time to get it.

Science: Why is COVID-19 surging again—and do shots still make sense?

USA Today: COVID-19 is surging and you can't find a booster? You're not alone.


Studies of COVID-flu combo vaccine move forward with some setbacks

Politico: The race for combo Covid-flu shots

CNBC: Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up

STAT: Pfizer and BioNTech effort to develop Covid-influenza combination vaccine sees setback


Flu shots already available in many US pharmacies; adjuvanted shot protects at-risk older adults better than high-dose version in study

CNET: Flu Shots Are Already Popping Up: When Do You Need One?

CIDRAP: Adjuvanted flu vaccine protects better than high-dose version in at-risk older adults, US data show

See also: Your Local Epidemiologist: A guide to fall 2024 vaccines


Pet cats, even those that live only indoors, are becoming infected with bird flu; new disease tracking system in US could help warn of outbreak   

New York Times: How Your Cat or Dog Could Warn of a Bird Flu Outbreak

Newsweek: America's Pet Cats Face Bird Flu Threat

The Telegraph: Indoor house cats have died of bird flu. How did they get it?


US risks bird flu pandemic if surveillance, mitigation gaps not filled on dairy farms, some experts warn; outbreaks upend traditions at livestock fairs  

New York Times: How U.S. Farms Could Start a Bird Flu Pandemic

AP: Bird flu restrictions cause heartache for 4-H kids unable to show livestock at fairs

Washington Post: Fear at the fair, and the cows stay home. A story of bird flu and tradition.

See also: The Guardian: New Zealand rushes vaccination of endangered birds before deadly strain of H5N1 bird flu arrives


Cambodia reports 10th fatal H5N1 avian flu case of year

CIDRAP: Cambodia reports fatal H5N1 avian flu case

Xinhua: Cambodian girl dies of H5N1 bird flu: health ministry


Larger proportion of people with antibodies to parvovirus B19, US CDC warns as many kids go back to school

Prevention: All About Parvovirus B19, the Virus That Causes a ‘Slapped Cheek’ Appearance

CBS News: What is parvovirus? Johns Hopkins doctor explains why it's a concern.


"The virus is spread very rapidly through respiratory droplets. School is going to be an opportunity for many different respiratory viruses to spread from person to person." – Dr. Amesh Adalja, Center for Health Security Senior Scholar


Following health alert on Oropouche, US CDC issues level 2 travel notice for people traveling to Cuba, particularly pregnant women

CIDRAP: CDC issues Oropouche virus alerts for clinicians and travelers

NPR: Oropouche virus 101: A guide to a little-known virus that's raising concern this year

Outbreak News Today: Oropouche fever Q&A


Georgia reports fifth measles infection; Oregon records 30 cases in largest outbreak since 1991

CIDRAP: Georgia reports another measles case as Oregon outbreak hits 30

Atlanta Journal-Constitution: Georgia health officials link a 5th case of measles this year to travel

Precision Vaccinations: Oregon's Measles Outbreak Impacts 30 Unvaccinated People


Global cholera cases down but deaths up; vaccine shortages endure; Sudan experiencing outbreak amid conflict, after severe flooding

CIDRAP: Global cholera cases decline, but deaths on the rise

AP: Cholera outbreak in Sudan has killed at least 22 people, health minister says


Ervebo Ebola vaccine 84% effective against infection during 2018–2020 outbreak in DRC, study shows

STAT: Merck Ebola vaccine Ervebo shown to offer substantial protection

CIDRAP: Study during DR Congo's outbreak finds 84% protection from Ebola vaccine


Aid groups call for ceasefire in Gaza to vaccinate more than 600K children against polio in coming weeks

AP: Aid groups in Gaza aim to avert a polio outbreak with a surge of vaccinations

Times of Israel: Blinken says US is working with Israel on plan to roll out Gaza polio vaccine drive


Humans, animals increasingly share landscapes, raising risk of disease outbreaks, study warns; antibiotic resistance in food animals poses threat to humans, researchers say

The Guardian: Humans to push further into wildlife habitats across more than 50% of land by 2070 – study

Newsweek: 'Big Pandemic Waiting to Happen,' Scientists Warn


Warming weather, geography, drinking water sources impact risk of waterborne infectious diseases, harmful cyanobacteria blooms

CIDRAP: Weather, location drive US waterborne infectious disease outbreaks, researchers say

Bloomberg: Deadly Bacteria Is a Growing Threat to Beach Vacations Across the US


Cucumbers, tiny pet turtles linked to salmonella outbreaks across US

Fox News: Salmonella outbreak caused by tiny turtles, CDC warns, with cases across 21 states

Salon: This summer's salmonella-laced cucumber recall linked to nearly 500 cases of illness

FROM THE CENTER

Center for Health Security Deputy Director Anita Cicero participates as panelist at CNAS event on biological national security


Johns Hopkins Center for Health Security Deputy Director Anita Cicero this week participated in a panel discussion as part of a Center for a New American Security (CNAS) project that aims to better understand AI risks and identify specific steps to improve AI safety and stability in national security applications. The panel, titled “AI and the Evolution of Biological National Security Risks,” examined how policymakers should approach AI and biosecurity, what risks are changing or remaining stable in the face of AI, and what actions need to be taken now or implemented in the future to monitor emerging threats. Cicero discussed next generation AI models, high-priority biosecurity risks, and the Center’s work in the field.


Bill Drexel, fellow in CNAS’s Technology and National Security Team, hosted the panel, which also featured Sonia Ben Ouagrham-Gormley, associate professor and deputy director of the Biodefense Graduate Program at George Mason University, and Stephanie Guerra, senior advisor at the US Artificial Intelligence Safety Institute.


A video recording of the event is available on the CNAS website: https://www.cnas.org/events/virtual-event-ai-and-the-evolution-of-biological-national-security-risks.


To keep up with news from the Center for Health Security, follow us on LinkedIn and X.

Editor: Alyson Browett, MPH

Contributing Editor: Prarthana Vasudevan, MS, MSPH, DrPH (c)

Give Today
Click to Subscribe
 
X  Youtube  Linkedin